Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation - Question and answer session after scientific review

被引:0
|
作者
Vincent, JL
Levi, M
Fisher, C
Reinhart, K
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 22 条
  • [11] Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis - Question and answer session after scientific review
    Vincent, JL
    Abraham, E
    Esmon, C
    Hack, CE
    CRITICAL CARE MEDICINE, 2000, 28 (09) : S33 - S33
  • [12] The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study
    Kudo, Daisuke
    Hayakawa, Mineji
    Iijima, Hiroaki
    Yamakawa, Kazuma
    Saito, Shinjiro
    Uchino, Shigehiko
    Iizuka, Yusuke
    Sanui, Masamitsu
    Takimoto, Kohei
    Mayumi, Toshihiko
    Azuhata, Takeo
    Ito, Fumihito
    Yoshihiro, Shodai
    Hayakawa, Katsura
    Nakashima, Tsuyoshi
    Ogura, Takayuki
    Noda, Eiichiro
    Nakamura, Yoshihiko
    Sekine, Ryosuke
    Yoshikawa, Yoshiaki
    Sekino, Motohiro
    Ueno, Keiko
    Okuda, Yuko
    Watanabe, Masayuki
    Tampo, Akihito
    Saito, Nobuyuki
    Kitai, Yuya
    Takahashi, Hiroki
    Kobayashi, Iwao
    Kondo, Yutaka
    Matsunaga, Wataru
    Nachi, Sho
    Miike, Toru
    Takahashi, Hiroshi
    Takauji, Shuhei
    Umakoshi, Kensuke
    Todaka, Takafumi
    Kodaira, Hiroshi
    Andoh, Kohkichi
    Kasai, Takehiko
    Iwashita, Yoshiaki
    Arai, Hideaki
    Murata, Masato
    Yamane, Masahiro
    Shiga, Kazuhiro
    Hori, Naoto
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [13] Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis
    Qi, Wenqian
    Liu, Jingyuan
    Li, Ang
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [14] Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis - Question and answer session after scientific review
    Vallet, B
    Grinnell, B
    Ulevitch, R
    CRITICAL CARE MEDICINE, 2001, 29 (07) : S60 - S61
  • [15] Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study
    Kudo, Daisuke
    Hayakawa, Mineji
    Ono, Kota
    Yamakawa, Kazuma
    THROMBOSIS RESEARCH, 2018, 163 : 22 - 29
  • [16] Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation
    Tagami, Takashi
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    FRONTIERS IN MEDICINE, 2015, 2
  • [17] A comparison of disseminated intravascular coagulation scoring systems and their performance to predict mortality in sepsis patients: A systematic review and meta-analysis
    Kiya, Girum Tesfaye
    Abebe, Gemeda
    Mekonnen, Zeleke
    Tadasa, Edosa
    Milkias, Gedion
    Asefa, Elsah Tegene
    PLOS ONE, 2025, 20 (01):
  • [18] Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients
    Moreno, G.
    Carbonell, R.
    Bodi, M.
    Rodriguez, A.
    MEDICINA INTENSIVA, 2021, 45 (01) : 42 - 55
  • [19] The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
    Toshiaki Iba
    Tomoki Tanigawa
    Hideo Wada
    Jerrold H. Levy
    Thrombosis Journal, 21
  • [20] The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
    Iba, Toshiaki
    Tanigawa, Tomoki
    Wada, Hideo
    Levy, Jerrold H.
    THROMBOSIS JOURNAL, 2023, 21 (01)